We are live on ! Find out more
NHC icon

National Healthcare

109 hedge funds and large institutions have $398M invested in National Healthcare in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 48 increasing their positions, 32 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more call options, than puts

Call options by funds: $5.04M | Put options by funds: $1.06M

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

50% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 32

6% more funds holding

Funds holding: 103109 (+6)

0.69% more ownership

Funds ownership: 36.65%37.34% (+0.69%)

0% more capital invested

Capital invested by funds: $397M → $398M (+$1.44M)

Holders
109
Holders Change
+6
Holders Change %
+5.83%
% of All Funds
2.72%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
48
Reduced
32
Closed
7
Calls
$5.04M
Puts
$1.06M
Net Calls
+$3.98M
Net Calls Change
-$2.85M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$62.4M +$1.55M +21,666 +2%
BlackRock
2
BlackRock
New York
$50.6M -$31.9K -446 -0.1%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$37.2M +$2.01M +28,157 +6%
Renaissance Technologies
4
Renaissance Technologies
New York
$29.6M +$4.5M +63,074 +18%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$26.5M -$7.46M -104,476 -22%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$26.2M -$376K -5,271 -1%
State Street
7
State Street
Massachusetts
$19.9M +$1.22M +17,106 +6%
Northern Trust
8
Northern Trust
Illinois
$17M +$1.64M +22,947 +10%
BBHC
9
Brown Brothers Harriman & Co
New York
$10.5M
Bank of New York Mellon
10
Bank of New York Mellon
New York
$9.23M +$51.4K +719 +0.5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$7.88M -$270K -3,778 -3%
Franklin Resources
12
Franklin Resources
California
$7.37M +$5.79K +81 +0.1%
ProShare Advisors
13
ProShare Advisors
Maryland
$6.91M +$57.1K +800 +0.8%
Thrivent Financial for Lutherans
14
Thrivent Financial for Lutherans
Minnesota
$5.4M -$340K -4,760 -6%
Bessemer Group
15
Bessemer Group
New Jersey
$4.31M -$97.6K -1,366 -2%
Russell Investments Group
16
Russell Investments Group
United Kingdom
$3.93M +$64.6K +904 +2%
SB
17
Suntrust Banks
Georgia
$3.73M -$144K -2,020 -4%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$3.69M +$958K +13,417 +34%
LSV Asset Management
19
LSV Asset Management
Illinois
$3.26M -$139K -1,947 -4%
Charles Schwab
20
Charles Schwab
California
$3.15M +$25.4K +356 +0.8%
MAM
21
Martingale Asset Management
Massachusetts
$2.93M +$150K +2,100 +5%
Deutsche Bank
22
Deutsche Bank
Germany
$2.82M +$2.21M +30,915 +330%
Morgan Stanley
23
Morgan Stanley
New York
$2.71M +$1.32M +18,492 +92%
Prudential Financial
24
Prudential Financial
New Jersey
$2.66M +$329K +4,610 +14%
Norges Bank
25
Norges Bank
Norway
$2.65M

NHC Hedge Fund Activity: Q2 2017 in Review

109 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q2 2017, worth a combined $398M — up 0.36% from $397M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new NHC positions and 7 closed out — a net gain of 6 holders — while 48 added to existing stakes and 32 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $4.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $7.46M.

  • 109 institutional investors held National Healthcare (NHC) as of Q2 2017, up from 103 in Q1 2017.
  • Funds reported $398M of National Healthcare stock for Q2 2017, up 0.36% quarter-over-quarter.
  • 13 funds opened new National Healthcare positions in Q2 2017 and 7 closed out, a net change of +6 holders.
  • The largest National Healthcare buyer in Q2 2017 was Renaissance Technologies, an estimated $4.5M added.
  • The largest National Healthcare seller in Q2 2017 was T. Rowe Price Associates, an estimated $7.46M sold.

Based on aggregated 13F filings for Q2 2017.